Pharmaceutical Biotechnology Co., Ltd. (Pharma Ming Biotech) proposes to amend its Articles of Association and Rules to comply with the latest amendments to the Securities Listing Rules of the Hong Kong Stock Exchange Limited regarding the electronic publication of the Company's communications. The amendment will involve the updating of certain provisions of the existing articles of association, in particular the manner in which shareholders are notified. The revised Articles of Association and Terms will allow the company to send notices and documents electronically to shareholders and will remove some outdated terms. The changes will be proposed in the form of a special resolution at the Annual General Meeting and are expected to be approved at the Annual General Meeting...Show More

Pharmaceutical Biotechnology Co., Ltd. (Pharma Ming Biotech) proposes to amend its Articles of Association and Rules to comply with the latest amendments to the Securities Listing Rules of the Hong Kong Stock Exchange Limited regarding the electronic publication of the Company's communications. The amendment will involve the updating of certain provisions of the existing articles of association, in particular the manner in which shareholders are notified. The revised Articles of Association and Terms will allow the company to send notices and documents electronically to shareholders and will remove some outdated terms. The changes will be proposed in the form of a special resolution at the Annual General Meeting and are expected to be approved at the Annual General Meeting to be held on June 19, 2024. Pharma Biologics will publish detailed circulars in accordance with the rules of the Listing, including the content of the proposed amendments and notice of the Annual General Meeting. Board members include Executive Director Dr. Chen Chi-sheng, Non-Executive Director Dr. Li Geng, etc., and Mr. William Robert Keller, Independent Non-Executive Director.